"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!

(fool-VESS-trant)
Faslodex
Solution for injection
50 mg/mL
Class: Antiestrogen

 Action Fulvestrant competitively binds to the estrogen receptor and downregulates the estrogen receptor protein in human breast cancer cells.

 Indications Treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

 Contraindications Pregnancy; hypersensitivity to the drug or any component of the product.

 Route/Dosage

Adults: IM 250 mg into buttock at 1-mo intervals.

 Interactions

None well documented.

 Lab Test Interferences None well documented.

 Adverse Reactions

CNS: Headache; dizziness; insomnia; paresthesia; depression; anxiety. DERMATOLOGIC: Rash; sweating. EENT: Pharyngitis. GI: Nausea; vomiting; constipation; diarrhea; abdominal pain; anorexia. GU: Urinary tract infection. HEMATOLOGIC: Anemia. RESPIRATORY: Dyspnea; increased cough. OTHER: Back pain; hot flushes; bone pain; arthritis; asthenia; pain; transient pain and inflammation at injection site; vasodilation; pelvic pain; peripheral edema; chest pain; flu-like syndrome; fever; accidental injury.

 Precautions

Pregnancy: Category D. Lactation: Undetermined. Children: Safety and efficacy not established.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • For IM administration only. Not for IV, SC, or ID administration.
  • Administer prescribed dose once monthly using prefilled syringe(s) and supplied safety needle(s).
  • Administer as single 5 mL injection or concurrent 2.5 mL injections into buttock.
  • Administer injection slowly.
  • Do not administer if cloudiness or particulate matter is noted.
  • Store prefilled syringes in refrigerator (36° to 46°C).

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note history of liver function impairment, bleeding diatheses, thrombocytopenia, or concurrent use of anticoagulants.
  • Ensure that patient has negative pregnancy test before starting therapy.
  • Monitor patient for GI, CNS, general body side effects, and injection site reactions. Inform health care provider if noted and significant.

 Patient/Family Education

  • Explain name, dose, action, and potential side effects of drug.
  • Advise patient that medication will be prepared and administered by health care provider in a health care setting on a monthly basis.
  • Instruct patient to inform health care provider if any of the following symptoms occur: intolerable nausea, vomiting, constipation, diarrhea, stomach pain, headache, hot flushes, injection site pain or inflammation.
  • Instruct patient to not take any prescription or otc medications or dietary supplements unless advised by health care provider.
  • Instruct women to notify health care provider if they become pregnant, plan on becoming pregnant, or are breastfeeding.
  • Advise patient that follow-up visits and laboratory tests will be required to monitor therapy and to be sure to keep appointments.

Popularity: 1% [?]


If you're still unable to find appropriate information in the article, please use search form below